2DY-33253-38857
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
5 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 524 / IA
- Registered
- 2021-02-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-19
Registered in v-safe
-
2021-02-19
Dose 1 — Moderna
-
2021-02-19
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain, Swelling · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-19
Report sent to call center — day 0, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-20
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-02-21
- 2021-02-23
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-25
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-02-26
Health check-in — day 7, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-26
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-03-12
Survey response — day 21, dose 1MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion, Sinus congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Headache, sinus pressure, congested, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-03-25
Dose 2 — Moderna
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-19 | Moderna | |
| 2 | 2021-03-25 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-19 | priority 2/3 | |
| 2021-02-20 | priority 2/3 | |
| 2021-02-25 | priority 2/3 | |
| 2021-02-26 | priority 2/3 | |
| 2021-03-12 | priority 2/3 |
Free text
Release 5 — day 21, dose 1
Symptoms: Headache, sinus pressure, congested, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release